CGRP therapies in acute migraine

preview_player
Показать описание
Following the US approval of the first CGRP small molecule receptor antagonist, ubrogepant, for the acute treatment of migraine, Peter Goadsby looks at the potential impact of targeting the CGRP pathway for both prevention and treatment of migraine.
  1. CGRP Education & Research Forum
Рекомендации по теме
CGRP therapies in 0:03:07

CGRP therapies in acute migraine

Development of Oral 0:07:26

Development of Oral CGRP Molecule Inhibitors for Acute Migraine

Acute and Preventive 0:52:29

Acute and Preventive Treatment of Migraine | Dr. Casper E. Christensen | ICAMS 2022

CGRP In the 0:05:16

CGRP In the Treatment & Prevention of Migraine - American Academy of Neurology

CGRP Inhibitors as 0:04:25

CGRP Inhibitors as Preventative Migraine Therapy

CGRP Inhibitors: Transformative 0:06:59

CGRP Inhibitors: Transformative Therapy for Migraine

Susan Hutchinson, MD: 0:01:38

Susan Hutchinson, MD: The Potential of the Gepant Class in Acute Migraine

CGRP Inhibitors as 0:04:25

CGRP Inhibitors as Preventative Migraine Therapy

The Role of 0:05:46

The Role of CGRP as Targeted Treatment for Migraine - Module 2: Ubrogepant

An Update in 0:59:53

An Update in Migraine Pathophysiology and CGRP Targeted Therapies - Grand Rounds SJHH

Migraine Prevention: New 0:56:52

Migraine Prevention: New Opportunities for Pain Relief

An Expert’s Perspective 0:37:32

An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Abs in Migraine Prevention

Advantages of oral 0:14:28

Advantages of oral anti-CGRP drugs in migraine prevention

Real-world studies of 0:05:33

Real-world studies of CGRP monoclonal antibodies and gepants for migraine

CGRP mAbs have 0:01:40

CGRP mAbs have changed migraine treatment approaches

The Role of 0:03:54

The Role of CGRP as Targeted Treatment for Migraine - Introduction

Acute Treatment of 0:46:18

Acute Treatment of Migraine with Gepants: When You Need to Act Fast

Administration and Dosage 0:04:39

Administration and Dosage of CGRP Monoclonal Antibodies

Migraine prevention in 0:18:18

Migraine prevention in the real world: Exploring the role of anti-CGRP antibodies

The updated guidelines 0:04:44

The updated guidelines for treating migraines with CGRP-targeted monoclonal antibodies

Rationale for Dual 0:29:17

Rationale for Dual Therapy with Therapies Targeting CGRP Signaling | Prof. Dodick | ICAMS 2022

Rimegepant Is Effective 0:02:34

Rimegepant Is Effective for Acute Migraine Pain at 2 Hours

Jessica Ailani, MD: 0:02:57

Jessica Ailani, MD: Long-Term Safety and Efficacy of Ubrogepant in Acute Migraine

2020 - Headache 0:44:58

2020 - Headache & Migraine - New Treatments - Dr. Elspeth Hutton